Ticker
BVSCompany Name
BIOVENTUS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
---|---|---|---|
6/30/2025 | $ 48.59M | $ 35.46M | $ 84.05M |
3/31/2025 | $ 49.63M | $ -1.94M | $ 47.69M |
12/31/2024 | $ 49.55M | $ -43K | $ 49.51M |
9/30/2024 | $ 49.62M | $ -6M | $ 43.62M |
6/30/2024 | $ 51.17M | $ -7.88M | $ 43.28M |
3/31/2024 | $ 52.68M | $ 20.81M | $ 73.49M |
12/31/2023 | $ 57.37M | $ -115.47M | $ -58.1M |
9/30/2023 | $ 68.06M | $ -140.8M | $ -72.74M |
6/30/2023 | $ 73.01M | $ -284.34M | $ -211.33M |
3/31/2023 | $ 70.8M | $ -295.06M | $ -224.26M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT + DepAmor
(=) EBITDA
EBITDA for BIOVENTUS INC is calculated as follows: EBIT [ $ 30.01M ] + DepAmor [ $ 30.32M ]
(=) EBITDA [ $ 60.32M ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.25K |
---|---|
min | $ -493.3M |
max | $ 590.6M |
average | $ 58.79M |
median | $ 8.83M |
std | $ 166.94M |